DSY Taurine 500mg Capsule
DSY Taurine 500mg Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| TAURINE | TAURINE[500 mg,640 mg] | Taurine |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- MAL23056050NC
- Type
- Health supplement
- Published status
- PRODUCT APPROVED
- Licence holder
- CTA NUTRICEUTICALS (ASIA) SDN BHD
- Manufacturer
- HERBAL SCIENCE SDN. BHD.
- Registration period starting
- 2023-05-16
- Published validity end
- 2028-05-16
Original register data
View published fields and their variants
- Active ingredients
- TAURINE[500 mg,640 mg]
- Valid until
- 2028-05-16
- Registration date
- 2023-05-16
- Published description
- HEALTH SUPPLEMENT
- Licence holder
- CTA NUTRICEUTICALS (ASIA) SDN BHD
- Producer
- HERBAL SCIENCE SDN. BHD.
- Published name
- DSY Taurine 500mg Capsule
- Published reference
- 2023030910645N
- Registration number
- MAL23056050NC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL23056050NC
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- TAURINE
Read the warning, when it applies and the studies cited
TAURINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).
Sources cited by Health Canada (2)
- López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
- Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “DSY Taurine 500mg Capsule”, https://compoatlas.com/en/supplements/malaysia/MAL23056050NC-dsy-taurine-500mg-capsule, updated 27 October 2026.